Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

Core Insights - Scilex Holding Company announced the confirmed claim process for the Dream Bowl 2026 Meme Coins, set to begin on December 24, 2025, for eligible shareholders [1][2]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products aimed at treating acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [4][6]. - The company targets high unmet needs in the market with its non-opioid therapies, aiming to improve patient outcomes [4]. Commercial Products - Scilex's commercial products include: - ZTlido® (lidocaine topical system) 1.8%, approved by the FDA for neuropathic pain relief [4]. - ELYXYB®, the only FDA-approved ready-to-use oral solution for acute migraine treatment in adults [4]. - Gloperba®, the first liquid oral version of colchicine for the prophylaxis of painful gout flares in adults [4]. Product Candidates - Scilex has three product candidates in development: - SP-102 (SEMDEXA), a viscous gel formulation for treating lumbosacral radicular pain, which has completed a Phase 3 study and received Fast Track status from the FDA [5]. - SP-103, a next-generation lidocaine topical system for acute pain, which has recently completed a Phase 2 trial and also received Fast Track status from the FDA [5]. - SP-104, a low-dose delayed-release naltrexone hydrochloride for fibromyalgia treatment [5].